Clinical Report: Guillain-Barré Syndrome Associated with Intracranial Hemorrhage

Overview

This review identifies 23 cases of Guillain-Barré syndrome (GBS) following intracranial hemorrhage (ICH).

Background

Guillain-Barré syndrome is an autoimmune disorder that can lead to severe neurological impairment and respiratory failure. The association between GBS and intracranial hemorrhage is noted.

Data Highlights

Key Findings

• GBS onset occurred a median of 9 days post-ICH.
• Intracerebral hemorrhage was the most common antecedent event (39.1%).
• Electrophysiological findings predominantly showed axonal variants.
• 78.3% of patients required mechanical ventilation due to respiratory failure.
• Among treated patients, 14.3% achieved complete recovery.

Clinical Implications

Clinicians should consider the possibility of GBS in patients with ICH who develop unexplained progressive weakness. Early initiation of immunotherapy may be beneficial in improving patient outcomes.

Conclusion

GBS can complicate recovery after ICH, presenting with an aggressive clinical course, particularly in axonal variants. Awareness and prompt management are essential for affected patients.

Related Resources & Content

1. Frontiers | Guillain-Barré syndrome Following Intracranial Hemorrhage: A Systematic Review of Case Reports
2. Case Series on Spontaneous Hematomas of the Spine
3. Relapsing Guillain–Barré syndrome associated with Graves’ disease and papillary thyroid carcinoma: a case report and literature review
4. Surgery for intracerebral hemorrhage: new evidence and changing perspectives
5. Frontiers in Pain Research — Guillain-Barré syndrome presenting with abdominal pain as the initial manifestation: a case report
6. https://pure.eur.nl/ws/files/115666592/European_Academy_of_Neurology_Peripheral_Nerve_Society_Guideline_on_diagnosis_and_treatment_of_Guillain_Barr_syndrome.pdf
7. GBS Guideline for AAN Members.qxd
8. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial | Medicines Awareness Service
9. Guillain–Barré syndrome | Nature Reviews Disease Primers
10. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association - PubMed
11. 2024 AHA/ASA Performance and Quality Measures for Spontaneous Intracerebral Hemorrhage: A Report From the American Heart Association/American Stroke Association - PubMed
12. Frontiers | Guillain-Barré syndrome Following Intracranial Hemorrhage: A Systematic Review of Case Reports
13. Intracerebral haemorrhage and Guillain-Barré syndrome: an exploration of potential pathophysiology - PMC
14. Frontiers | Multiple cerebral infarctions after intravenous immunoglobulin for Guillain–Barré syndrome: two case reports and review of the literature